CYP3A5 and ABCB1 Polymorphisms as Predictors for Sunitinib Outcome in Metastatic Renal Cell Carcinoma by Diekstra, Meta H.M, Swen, Jesse J, Boven, Epie, Castellano, Daniel, Gelderblom, Hans, Mathijssen, Ron H.J, Rodríguez-Antona, Cristina, García-Donas, Jesus, Rini, Brian I, Guchelaar, Henk-Jan

Get full text

Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer—GEnetic- and tumor-related biomarkers for response and toxicity by van der Zanden, Loes F.M., Ph.D, Vermeulen, Sita H., Ph.D, Oskarsdottir, Arna, M.Sc, Maurits, Jake S.F., M.Sc, Diekstra, Meta H.M., M.Pharm, Ambert, Valentin, M.D, Cambon-Thomsen, Anne, M.D., D.R., C.N.R.S, Castellano, Daniel, Fritsch, Achim, R.Ph, Garcia Donas, Jesus, M.D., Ph.D, Guarch Troyas, Rosa, M.D, Guchelaar, Henk-Jan, Pharm.D., Ph.D, Hartmann, Arndt, M.D, Hulsbergen-van de Kaa, Christina, M.D., Ph.D, Jaehde, Ulrich, Ph.D, Junker, Kerstin, Ph.D, Martinez-Cardus, Anna, Ph.D, Masson, Gisli, Ph.D, Oosterwijk-Wakka, Jeannette, Ph.D, Radu, Marius T., M.D, Rafnar, Thorunn, Ph.D, Rodriguez-Antona, Cristina, Ph.D, Roessler, Max, Ph.D, Ruijtenbeek, Rob, Ph.D, Stefansson, Kari, M.D., Ph.D, Warren, Anne, M.B.B.S., M.Sc., F.R.C.Path, Wessels, Lodewyk, Ph.D, Eisen, Tim, F.R.C.P., Ph.D, Kiemeney, Lambertus A.L.M., Ph.D, Oosterwijk, Egbert, Ph.D

Get full text

Letter to the editor: Comments on ‘A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation’ by Diekstra, Meta H.M., Malmberg, Ruben, Sleijfer, Stefan, van Leeuwen, Roelof W.F.

Get full text

Practical Recommendations for the Manipulation of Kinase Inhibitor Formulations to Age-Appropriate Dosage Forms by Bernsen, Emma C, Hogenes, Valery J, Nuijen, Bastiaan, Hanff, Lidwien M, Huitema, Alwin D R, Diekstra, Meta H M

Get full text

Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma by Diekstra, Meta H. M., Liu, Xiaoyan, Swen, Jesse J., Boven, Epie, Castellano, Daniel, Gelderblom, Hans, Mathijssen, Ron H. J., Rodríguez-Antona, Cristina, García-Donas, Jesus, Rini, Brian I., Guchelaar, Henk-Jan

Get full text

A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma by Liu, Xiaoyan, Swen, Jesse J, Diekstra, Meta H M, Boven, Epie, Castellano, Daniel, Gelderblom, Hans, Mathijssen, Ron H J, Vermeulen, Sita H, Oosterwijk, Egbert, Junker, Kerstin, Roessler, Max, Alexiusdottir, Kristin, Sverrisdottir, Asgerdur, Radu, Marius T, Ambert, Valentin, Eisen, Tim, Warren, Anne, Rodríguez-Antona, Cristina, García-Donas, Jesus, Böhringer, Stefan, Koudijs, Karel K M, Kiemeney, Lambertus A L M, Rini, Brian I, Guchelaar, Henk-Jan

Get full text

Genome-Wide Meta-Analysis Identifies Variants in DSCAM and PDLIM3 That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib by Diekstra, Meta H M, Swen, Jesse J, van der Zanden, Loes F M, Vermeulen, Sita H, Boven, Epie, Mathijssen, Ron H J, Fukunaga, Koya, Mushiroda, Taisei, Hongo, Fumiya, Oosterwijk, Egbert, Cambon-Thomsen, Anne, Castellano, Daniel, Fritsch, Achim, Donas, Jesus Garcia, Rodriguez-Antona, Cristina, Ruijtenbeek, Rob, Radu, Marius T, Eisen, Tim, Junker, Kerstin, Roessler, Max, Jaehde, Ulrich, Miki, Tsuneharu, Böhringer, Stefan, Kubo, Michiaki, Kiemeney, Lambertus A L M, Guchelaar, Henk-Jan

Get full text

Logical Imputation to Optimize Prognostic Risk Classification in Metastatic Renal Cell Cancer by Maurits, Jake S.F., van der Zanden, Loes F.M., Diekstra, Meta H.M., Ambert, Valentin, Castellano, Daniel, Garcia-Donas, Jesus, Troyas, Rosa Guarch, Guchelaar, Henk-Jan, Jaehde, Ulrich, Junker, Kerstin, Martinez-Cardus, Anna, Radu, Marius T., Rodriguez-Antona, Cristina, Roessler, Max, Warren, Anne, Eisen, Tim, Oosterwijk, Egbert, Kiemeney, Lambertus A.L.M., Vermeulen, Sita H.

Get full text